Literature DB >> 28993442

In-room assessment of intravascular velocity from time-resolved rotational angiography in patients with arteriovenous malformation: a pilot study.

Chung Jung Lin1,2, Huai Che Yang2,3, Ai Chi Chien4, Wan Yuo Guo1,2, Chih Chun Wu1,2, Sheng Che Hung1,2, Ko Kung Chen5, Hsiu Mei Wu1,2, Chao Bao Luo1,2, Wei Fa Chu1,2, Jia Sheng Hong5, Chun Shien Frank Wu6.   

Abstract

BACKGROUND: Time-resolved rotational angiography (t-RA) enables interventionists to better comprehend complex arteriovenous malformations (AVMs), thereby facilitating endovascular treatment. However, its use in evaluating hemodynamic changes has rarely been explored.
OBJECTIVE: This study uses t-RA to estimate intravascular flow in patients with AVM to compare this with flow in the normal population.
METHODS: Patients with available t-RA scans were prospectively categorized into one of three groups: hemorrhagic AVM, non-hemorrhagic AVM and control. Pulsatile time-density curves (TDCs) for C1, C6 and VOIMCA were used for amplitude and velocity estimation. C1 was at the cervical internal carotid artery (ICA), 2-3 cm below the carotid canal, C6 was at the paraclinoid segment of the ICA, and VOIMCA was at the junction of the first and second segment of the middle cerebral artery (MCA). A waveform amplitude ratio was defined as (peak - trough)/trough contrast intensity. VICA was defined as the distance between C6 and C1 divided by the time required for the wave to pass, and correspondingly, the average velocity of MCA (VMCA) was defined as the distance between C6 and VOIMCA divided by the duration for the same peak to travel from C6 and VOIMCA, AVM volume was estimated by MR angiography.
RESULTS: Amplitude ratios AC1 and AC6, and average flow velocities VICA and VMCA were significantly larger in the non-hemorrhagic group than in the control group, while the hemorrhagic AVM group was not significantly different from the controls. VICA and VMCA showed moderate to good correlations with AVM volume (r=0.51 and 0.73, respectively). VMCA (33.0±9.1) was significantly lower than VICA (41.3±13.2) in the control group, but not in the two AVM groups.
CONCLUSION: TDC waveform propagation derived from t-RA can quantify hemodynamic differences between AVM and the control group. t-RA provides both real-time anatomic and hemodynamic evaluation, and can thus potentially improve the interventional workflow. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  arteriovenous malformation; blood velocity; hemorrhage; time density curve; time-resolved rotational angiograph

Mesh:

Year:  2017        PMID: 28993442     DOI: 10.1136/neurintsurg-2017-013387

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  5 in total

1.  Optimizing the Quality of 4D-DSA Temporal Information.

Authors:  K L Ruedinger; E C Harvey; S Schafer; M A Speidel; C M Strother
Journal:  AJNR Am J Neuroradiol       Date:  2019-10-31       Impact factor: 3.825

2.  Plasma Matrix Metalloproeteinase-9 Is Associated with Seizure and Angioarchitecture Changes in Brain Arteriovenous Malformations.

Authors:  Yo-Tsen Liu; Cheng-Chia Lee; Chun-Fu Lin; Hsiu-Mei Wu; Wan-Yuo Guo; Huai-Che Yang; Feng-Chi Chang; Kang-Du Liou; Chung-Jung Lin
Journal:  Mol Neurobiol       Date:  2022-07-12       Impact factor: 5.682

Review 3.  4D-DSA: Development and Current Neurovascular Applications.

Authors:  K L Ruedinger; S Schafer; M A Speidel; C M Strother
Journal:  AJNR Am J Neuroradiol       Date:  2020-11-26       Impact factor: 3.825

Review 4.  Risk factors for hemorrhage of brain arteriovenous malformation.

Authors:  Sonali S Shaligram; Ethan Winkler; Daniel Cooke; Hua Su
Journal:  CNS Neurosci Ther       Date:  2019-07-29       Impact factor: 5.243

5.  Simulation of superselective catheterization for cerebrovascular lesions using a virtual injection software.

Authors:  Sri Hari Sundararajan; Srirajkumar Ranganathan; Vaishnavi Kishore; Raphael Doustaly; Athos Patsalides
Journal:  CVIR Endovasc       Date:  2021-06-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.